Literature DB >> 11820141

Hyperbaric oxygen and surgery.

C MacFarlane1, F J Cronjé.   

Abstract

Hyperbaric oxygen (HBO) therapy, that is the administration of 100% oxygen delivered under pressure, has a beneficial effect in several surgical conditions. Its use has been assessed and audited and its pharmacological effects demonstrated. It is appropriate for use in several surgical conditions as evidence-based therapy. These are: (i) gas gangrene; (ii) crush injuries, compartment syndromes and acute traumatic ischemias; (iii) enhancement of healing in selected problem wounds; (iv) exceptional blood loss anaemia; (v) necrotising soft-tissue infections; (vi) refractory osteomyelitis; (vii) radionecrosis; (viii) compromised skin grafts and flaps; (ix) thermal burns; (x) intracranial abscess. HBO therapy has been used inappropriately in the past; there is also lack of knowledge regarding its application, and scarce hyperbaric facilities. Hyperbaric therapy, when properly supervised by a physician trained in its use, working closely with a surgeon, and ethically used for appropriate indications, can be a useful adjunct to surgical practice.

Entities:  

Mesh:

Year:  2001        PMID: 11820141

Source DB:  PubMed          Journal:  S Afr J Surg        ISSN: 0038-2361            Impact factor:   0.375


  3 in total

1.  Hyperbaric Oxygen Preconditioning Provides Preliminary Protection Against Doxorubicin Cardiotoxicity.

Authors:  Orhan Tezcan; Oguz Karahan; Mustafa Alan; Cenap Ekinci; Celal Yavuz; Sinan Demirtas; Aysun Ekinci; Ahmet Caliskan
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

2.  Treatment of skin necrosis after radiation synovectomy with yttrium-90: a case report.

Authors:  Hayati Oztürk; Zekeriya Oztemür; Okay Bulut
Journal:  Rheumatol Int       Date:  2008-03-28       Impact factor: 2.631

3.  Effects of hyperbaric oxygen and Pgg-glucan on ischemic colon anastomosis.

Authors:  Suna Guzel; Oguzhan Sunamak; Abdullah AS; Varol Celik; Mehmet Ferahman; Muhammed M K Nuri; Ertugrul Gazioglu; Pinar Atukeren; Ozgur Mutlu
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.